Trulicity (dulaglutide): Complete Guide 2026
Trulicity (dulaglutide) is a once-weekly injectable GLP-1 receptor agonist approved for type 2 diabetes. Known for its easy-to-use, single-dose autoinjector pen that doesn't require needle handling, Trulicity has been one of the most prescribed GLP-1 medications worldwide. The REWIND cardiovascular outcomes trial demonstrated that Trulicity reduces the risk of major cardiovascular events. It provides moderate weight loss of approximately 5-7% alongside significant blood sugar improvements.
Enzo's Tip
Trulicity's pre-filled pen is as easy as it gets — no mixing, no needle-handling, just click and done! Enzo appreciates simplicity (more time for naps). It comes in a ready-to-use autoinjector, so even if needles make you nervous, Trulicity has your back! 💪🐱
Track your Trulicity journey with Enzo
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Quick Facts
| Generic Name | dulaglutide |
| Manufacturer | Eli Lilly |
| Type | Injectable pen |
| Frequency | Once weekly |
| Primary Indication | Type 2 diabetes |
Trulicity Guides
Enzo reminds you when your next Trulicity dose is due
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Frequently Asked Questions
The guide your doctor doesn't have time to give you
Your complete Trulicity playbook: week-by-week guide, what to eat when nothing sounds good, and how to manage every side effect. Free.
No spam. Unsubscribe anytime.
Medical Disclaimer: Enzo is a tracking companion, not a doctor. Always consult your healthcare provider before starting, stopping, or changing any medication. The information on this page is for educational purposes only and should not be considered medical advice. Individual results may vary.